TABLE 2.
Homogenate | Cytosol | Mitochondria | |
---|---|---|---|
Liver | |||
No addition | 0.69±0.02 | 1.06±0.29 | 4.01±0.13 |
+ 5 mM D,L-Propargylglycine | 0.19±0.04* | 0.23±0.11* | 2.79±0.17** |
+ 0.5 mM KG | 0.75±0.06 | 1.34±0.14 | 3.66±0.52 |
+ 0.5 mM KMB | 0.65±0.06 | 1.23±0.32 | 2.50±0.33*** |
Kidney | |||
No addition | 1.18±0.09 | ND | ND |
Brain | |||
No addition | 0.23±0.03 | ND | ND |
The standard reaction mixture (20 μL) contained 5 mM THT-A, 100 mM potassium phosphate buffer (pH 7.4) and the indicated tissue fraction. After incubation at 37 °C, pyruvate was determined by the 2,4-dinitrophenylhydrazone procedure as outlined in the Materials and Methods section. The blank contained phosphate buffer plus tissue fraction incubated at 37 °C. At the end of the incubation period, 2 μL of 50 mM THT-A was added just prior to addition of the 2,4-dinitrophenylhydrazine reagent. A correction was made for the slow non-enzymatic conversion rate of THT-A to pyruvate under the incubation conditions (n = 3 to 6 determinations). ND, not determined. The amount of protein (μg) in each assay mixture was as follows: liver homogenate (324), liver cytosol (53), liver mitochondria (43), kidney homogenate (76) and brain homogenate (160). The time of incubation (min) was as follows: liver homogenate (30), liver cytosol (120), liver mitochondria (120), kidney homogenate (120) and brain homogenate (120).
Significant differences between “no addition” and “addition” values are
P = 0.05
P = 0.025
P = 0.0025.